J. Michael Wells

7.9k total citations · 2 hit papers
100 papers, 3.2k citations indexed

About

J. Michael Wells is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, J. Michael Wells has authored 100 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Pulmonary and Respiratory Medicine, 25 papers in Physiology and 15 papers in Molecular Biology. Recurrent topics in J. Michael Wells's work include Chronic Obstructive Pulmonary Disease (COPD) Research (60 papers), Respiratory Support and Mechanisms (21 papers) and Asthma and respiratory diseases (19 papers). J. Michael Wells is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (60 papers), Respiratory Support and Mechanisms (21 papers) and Asthma and respiratory diseases (19 papers). J. Michael Wells collaborates with scholars based in United States, United Kingdom and Saudi Arabia. J. Michael Wells's co-authors include Mark T. Dransfield, Surya P. Bhatt, J. Edwin Blalock, Amit Gaggar, Hrudaya Nath, George R. Washko, Fiona M. Watt, Russell P. Bowler, Barry J. Make and Anand Iyer and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

J. Michael Wells

97 papers receiving 3.2k citations

Hit Papers

Activated PMN Exosomes: Pathogenic Entities... 2012 2026 2016 2021 2019 2012 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung
    2019 336 citations Kristopher R. Genschmer, Derek W. Russell et al. Cell profile →
  2. Pulmonary Arterial Enlargement and Acute Exacerbations of COPD
    2012 320 citations J. Michael Wells, George R. Washko et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Michael Wells United States 29 2.0k 702 623 421 255 100 3.2k
D. Kyle Hogarth United States 30 1.6k 0.8× 852 1.2× 414 0.7× 193 0.5× 127 0.5× 94 2.5k
S. Marchand‐Adam France 34 2.2k 1.1× 773 1.1× 629 1.0× 165 0.4× 476 1.9× 132 3.6k
Ralph J. Panos United States 29 1.7k 0.8× 358 0.5× 635 1.0× 176 0.4× 184 0.7× 90 2.7k
Philippe Bonniaud France 34 2.5k 1.3× 586 0.8× 1.2k 1.9× 176 0.4× 302 1.2× 134 4.8k
Uwe Querfeld Germany 37 856 0.4× 353 0.5× 794 1.3× 716 1.7× 226 0.9× 163 4.7k
Kewu Huang China 24 956 0.5× 836 1.2× 221 0.4× 203 0.5× 512 2.0× 103 2.1k
Nazia Chaudhuri United Kingdom 24 2.0k 1.0× 572 0.8× 242 0.4× 110 0.3× 158 0.6× 100 2.7k
Wim Wuyts Belgium 39 4.1k 2.1× 1.6k 2.3× 511 0.8× 215 0.5× 406 1.6× 199 5.3k
Gerard M. Turino United States 38 2.6k 1.3× 656 0.9× 656 1.1× 258 0.6× 198 0.8× 140 4.6k
Han-Pin Kuo Taiwan 32 1.6k 0.8× 487 0.7× 548 0.9× 124 0.3× 681 2.7× 79 3.7k

Countries citing papers authored by J. Michael Wells

Since Specialization
Citations

This map shows the geographic impact of J. Michael Wells's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Michael Wells with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Michael Wells more than expected).

Fields of papers citing papers by J. Michael Wells

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Michael Wells. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Michael Wells. The network helps show where J. Michael Wells may publish in the future.

Co-authorship network of co-authors of J. Michael Wells

This figure shows the co-authorship network connecting the top 25 collaborators of J. Michael Wells. A scholar is included among the top collaborators of J. Michael Wells based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Michael Wells. J. Michael Wells is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dunbar, Karen J., Su‐Hyung Lee, Yoonkyung Won, et al.. (2025). A Cell Marker Atlas to Distinguish Metaplastic Transitions in Human Esophagus and Stomach. Cellular and Molecular Gastroenterology and Hepatology. 19(12). 101611–101611. 1 indexed citations
2.
Tornabene, Patrizia & J. Michael Wells. (2024). Exploring optimal protocols for generating and preserving glucose-responsive insulin-secreting progenitor cells derived from human pluripotent stem cells. European Journal of Cell Biology. 103(4). 151464–151464. 1 indexed citations
3.
Joshi, Rashika, Qiang Fan, Aleksey Porollo, et al.. (2024). Anti-CELA1 antibody KF4 prevents emphysema by inhibiting stretch-mediated remodeling. JCI Insight. 9(1).
4.
Wells, J. Michael, et al.. (2021). The immunological response among COVID-19 patients with acute respiratory distress syndrome. Journal of Infection and Public Health. 14(7). 954–959. 4 indexed citations
5.
Payne, Gregory A., Nirmal Sharma, Charitharth Vivek Lal, et al.. (2021). Prolyl endopeptidase contributes to early neutrophilic inflammation in acute myocardial transplant rejection. JCI Insight. 6(6). 5 indexed citations
6.
Roda, Mojtaba Abdul, Xin Xu, Tarek Abdalla, et al.. (2019). Proline-Glycine-Proline Peptides are Critical in the Development of Smoke-induced Emphysema. American Journal of Respiratory Cell and Molecular Biology. 61(5). 560–566. 18 indexed citations
7.
Genschmer, Kristopher R., Derek W. Russell, Charitharth Vivek Lal, et al.. (2019). Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung. Cell. 176(1-2). 113–126.e15. 336 indexed citations breakdown →
8.
Gulati, Swati, Aline N. Zouk, Christopher Wren, et al.. (2018). The use of a standardized order set reduces systemic corticosteroid dose and length of stay for individuals hospitalized with acute exacerbations of COPD: a cohort study. International Journal of COPD. Volume 13. 2271–2278. 11 indexed citations
9.
Aggarwal, Saurabh, Israr Ahmad, Adam Lam, et al.. (2018). Heme scavenging reduces pulmonary endoplasmic reticulum stress, fibrosis, and emphysema. JCI Insight. 3(21). 47 indexed citations
10.
Larson‐Casey, Jennifer L., Linlin Gu, Patricia L. Jackson, et al.. (2018). Macrophage Rac2 Is Required to Reduce the Severity of Cigarette Smoke–induced Pneumonia. American Journal of Respiratory and Critical Care Medicine. 198(10). 1288–1301. 10 indexed citations
11.
Iyer, Anand, J. Michael Wells, Surya P. Bhatt, et al.. (2018). Life-Space mobility and clinical outcomes in COPD. International Journal of COPD. Volume 13. 2731–2738. 30 indexed citations
12.
Bhatt, Surya P., Gonzalo Vegas‐Sánchez‐Ferrero, Farbod N. Rahaghi, et al.. (2017). Cardiac Morphometry on Computed Tomography and Exacerbation Reduction with β-Blocker Therapy in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 196(11). 1484–1488. 11 indexed citations
13.
Bhatt, Surya P., John E. Connett, Helen Voelker, et al.. (2016). β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol. BMJ Open. 6(6). e012292–e012292. 22 indexed citations
14.
Dransfield, Mark T., Ken M. Kunisaki, Matthew Strand, et al.. (2016). Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 195(3). 324–330. 230 indexed citations
15.
Wells, J. Michael, Patricia L. Jackson, Liliana Viera, et al.. (2015). A Randomized, Placebo-controlled Trial of Roflumilast. Effect on Proline-Glycine-Proline and Neutrophilic Inflammation in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 192(8). 934–942. 47 indexed citations
16.
Lee, Jin Hwa, Michael H. Cho, Craig P. Hersh, et al.. (2014). IREB2 and GALC Are Associated with Pulmonary Artery Enlargement in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology. 52(3). 365–376. 23 indexed citations
17.
Bhatt, Surya P., J. Michael Wells, Victor Kim, et al.. (2014). Paradoxical response to bronchodilators: Radiologic correlates and clinical implications. European Respiratory Journal. 44(Suppl 58). 4634–4634. 1 indexed citations
18.
Wells, J. Michael, Philip O’Reilly, Tomasz Szul, et al.. (2014). An Aberrant Leukotriene A4 Hydrolase–Proline-Glycine-Proline Pathway in the Pathogenesis of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 190(1). 51–61. 50 indexed citations
19.
O’Reilly, Philip, Patricia L. Jackson, J. Michael Wells, et al.. (2013). Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations. BMJ Open. 3(12). e004140–e004140. 32 indexed citations
20.
Estépar, Raúl San Jośe, Gregory L. Kinney, Jennifer L. Black‐Shinn, et al.. (2013). Computed Tomographic Measures of Pulmonary Vascular Morphology in Smokers and Their Clinical Implications. American Journal of Respiratory and Critical Care Medicine. 188(2). 231–239. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Kyle Hogarth Breakdown of academic impact, for papers by S. Marchand‐Adam Breakdown of academic impact, for papers by Ralph J. Panos Breakdown of academic impact, for papers by Philippe Bonniaud Breakdown of academic impact, for papers by Uwe Querfeld Breakdown of academic impact, for papers by Kewu Huang Breakdown of academic impact, for papers by Nazia Chaudhuri Breakdown of academic impact, for papers by Wim Wuyts Breakdown of academic impact, for papers by Gerard M. Turino Breakdown of academic impact, for papers by Han-Pin Kuo
Rankless by CCL
2026